Status:

RECRUITING

F15 Recharge Free Axonics SNM System Clinical Study

Lead Sponsor:

Axonics, Inc.

Conditions:

Urinary Urge Incontinence (UUI)

Urinary Frequency (UF)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Multicenter, prospective, non randomized, single arm evaluation of patients with overactive bladder (OAB) and/or fecal incontinence (FI) employing the Axonics recharge free SNM System.

Detailed Description

A clinical evaluation to comply with new European Medical Device Regulations (EU MDR) guidelines. Multicenter, prospective, non-randomized, single arm study for OAB and/or FI to assess the safety and ...

Eligibility Criteria

Inclusion

  • 18 years or older
  • Primary indication of overactive bladder (OAB) (urinary urgency incontinence (UUI)/ urinary frequency (UF)) or fecal incontinence (FI) who are not candidates for, or who have failed conservative treatment
  • Willing and capable to provide written informed consent and agrees to comply with specified evaluations at clinical investigational sites and attend all follow-up assessments for up to 1 year.

Exclusion

  • Any significant medical condition that is likely to interfere with procedures, device operation, or likely to confound evaluation of endpoints (exclusion of neurological conditions such as multiple sclerosis)
  • Any psychiatric or personality disorder that is likely to interfere with procedures at the discretion of the participating physician; this may include poor understanding or compliance with requirements
  • Previously underwent an external sacral neuromodulation (SNM) trial and was deemed a non-responder or was previously implanted with a sacral neuromodulation device and did not get therapeutic benefit (a non-responder)
  • History of allergic response to titanium, zirconia, polyurethane, epoxy, or silicone
  • A female who is breastfeeding
  • A female with a positive urine pregnancy test

Key Trial Info

Start Date :

December 8 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2027

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06186765

Start Date

December 8 2023

End Date

March 1 2027

Last Update

December 23 2025

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Hartford Healthcare

Waterford, Connecticut, United States, 06385

2

Florida Gulf Clinical Research

Bradenton, Florida, United States, 34205

3

East Coast Institute of Research

Jacksonville, Florida, United States, 32216

4

Florida Bladder Institute

Naples, Florida, United States, 34109